|
|
Volumn 306, Issue 15, 2011, Pages 1642-1643
|
|
HIV/AIDS funding dropped by 10% in 2010
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
GENERIC DRUG;
STAVUDINE;
TENOFOVIR;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
AUSTRALIA;
COMMUNITY CARE;
COMPETITION;
COST BENEFIT ANALYSIS;
DECENTRALIZATION;
DEVELOPING COUNTRY;
DRUG COST;
ECONOMIC RECESSION;
FUNDING;
GOVERNMENT REGULATION;
HEALTH CARE ACCESS;
HEALTH CARE COST;
HEALTH CARE DELIVERY;
HEALTH CARE FINANCING;
HEALTH CARE ORGANIZATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INVESTMENT;
PRIORITY JOURNAL;
SHORT SURVEY;
TREATMENT PLANNING;
TREND STUDY;
UNITED STATES;
WORLD HEALTH ORGANIZATION;
|
|
EID: 80054775584
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2011.1478 Document Type: Short Survey |
|
Times cited : (3)
|
|
References (0)
|
